Kara Mizokami-Stout
Assistant Professor of Internal Medicine

Available to mentor
Kara Mizokami-Stout
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
    • About

    Kara Mizokami-Stout, MD, MSc is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes. She attended medical school and internal medicine residency at the University of Colorado. She then completed her endocrinology fellowship at the University of Michigan. She joined the faculty at the University of Michigan in 2017 and has a dual appointment at the Ann Arbor VA.

    Qualifications
    • Postdoctoral Research Fellow, VA Scholar, Health Services Research Fellowship Program, National Clinician Scholars Program, Institute of Healthcare Innovation and Policy
      University of Michigan, Ann Arbor, MI, 2020
    • Clinical Trials Academy
      University of Michigan, Ann Arbor, MI, 2018
    • Metabolism, Endocrinology, and Diabetes Fellowship
      University of Michigan, Ann Arbor, MI, 2017
    • Internal Medicine Residency
      University of Colorado, Aurora, CO, 2015
    • MSc, Health and Health Policy
      University of Michigan Rackham Graduate School, Ann Arbor, MI, 2019
    • MD, Doctor of Medicine
      University of Colorado Anschutz Medical Campus, Aurora, CO, 2012
    • BS, Biology and Biochemistry
      Regis University, Denver, CO, 2006
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      Precision Health Initiative
    Research Overview

    Dr. Mizokami-Stout’s research interest is in diabetes health services research with a particular focus on implementing technologies to improve diabetes self-management and prevent diabetes complications.

    Recent Publications See All Publications
    • Journal Article
      The Michigan Collaborative for Type 2 Diabetes (MCT2D): Development and implementation of a statewide collaborative quality initiative.
      Oshman L, Bhomia N, Diez HL, Gabison J, Gorin SS, Griauzde DH, Hisamatsu R, Heung M, Jamison CD, Khosrovaneh K, Kim N, Lee JM, Mizokami-Stout K, Pop-Busui R, Rau J, Reiss J, Saran R, Young L, Aikens JE, Richardson C. BMC Health Serv Res, 2024 Oct 17; 24 (1): 1254 DOI:10.1186/s12913-024-11520-z
      PMID: 39420291
    • Presentation
      From Guidelines to Practice: Recent Advances in Type 2 Diabetes Therapy
      Mizokami-Stout K. 2024 Nov 8;
    • Presentation
      From Finger-pricks to Real-time Insights: Continuous Glucose Monitoring in Type 2 Diabetes
      Mizokami-Stout K. 2024 Oct 22;
    • Presentation
      The Psychological Burden of Diabetic Neuropathy
      Mizokami-Stout K. 2024 Sep 6;
    • Presentation
      Epidemiology and Clinical Impact
      Mizokami-Stout K, Rayman G. 2024 Sep 5;
    • Presentation
      Epidemiology and Clinical Impact
      Mizokami-Stout K, Rayman G. 2024 Sep 5;
    • Journal Article
      Bidirectional Associations Between Mental Health Disorders and Chronic Diabetic Complications in Individuals With Type 1 or Type 2 Diabetes.
      Watanabe M, Reynolds EL, Banerjee M, Charles M, Mizokami-Stout K, Albright D, Ang L, Lee JM, Pop-Busui R, Feldman EL, Callaghan BC. Diabetes Care, 2024 Sep 1; 47 (9): 1638 - 1646. DOI:10.2337/dc24-0818
      PMID: 39008530
    • Journal Article
      The impact of statin therapy on the healing of diabetic foot ulcers: a case-control series.
      O'Dell B, Rothenberg G, Holmes C, Priesand S, Mizokami-Stout K, Brandt EJ, Schmidt BM. Clin Diabetes Endocrinol, 2024 Jul 10; 10 (1): 19 DOI:10.1186/s40842-024-00175-8
      PMID: 38982504